News & insights

Taylor Wessing advises Sunday Natural on the sale of a stake to CVC

by multiple authors

11. January 2024 – CJEU Case C 473/22: Mylan AB v Gilead and others

Germany as a location for pharmaceutical businesses - quo vadis, 2024?

Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany

by Irina Rebin

Work/Life: international employment news update

by multiple authors

Taylor Wessing advises greentech on the realization and sale of the Agethorst solar park and on the conclusion of PPAs

by multiple authors

Taylor Wessing advises Encavis Asset Management AG on the acquisition of two further wind farms in Brandenburg from UKA

by multiple authors

The interfaces between artificial intelligence and the Data Act

by Dr. Carolin Monsees, CIPP/E and Stephanie Richter, LL.M. (Torino), CIPP/E

The Top 10 Changes for Foreign Companies Under China’s New Company Law

by Kai Kim (né Schlender), M.A.

GDPR compensation and culpability

by Alexander Schmalenberger, LL.B. and Dr. Benedikt Kohn, CIPP/E